Renaissance Technologies - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 14 filers reported holding CYCLO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$28
-100.0%
17,800
-63.3%
0.00%
Q3 2022$94,000
-25.4%
48,494
-24.2%
0.00%
Q2 2022$126,000
-47.5%
63,986
-15.6%
0.00%
Q1 2022$240,000
-2.8%
75,787
+14.3%
0.00%
Q4 2021$247,000
+247.9%
66,300
+532.5%
0.00%
Q3 2021$71,00010,4820.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Renaissance Technologies 75,787$240,0000.00%
ROYAL BANK OF CANADA 746$2,0000.00%
VANGUARD GROUP INC 255,065$808,0000.00%
UBS Group AG 2,291$7,0000.00%
IFP Advisors, Inc 26$2,0000.00%
WELLS FARGO & COMPANY/MN 2,047$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 48,316$153,0000.00%
STATE STREET CORP 28,300$90,0000.00%
CITIGROUP INC 1,232$4,0000.00%
View complete list of CYCLO THERAPEUTICS INC shareholders